“We remain cautiously optimistic on the market and suggest continuing with the “buy on dips” approach until we see a reversal in the trend. Going ahead, earnings, global cues and progress on vaccine drive will dictate the trend,” said Ajit Mishra, VP – Research, Religare Broking.
